# Osimertinib As First-Line Treatment of <i>EGFR</i> Mutation–Positive Advanced Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/osimertinib-as-first-line-treatment-of-i-egfr-i-mutation-positive-advanced-non/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Suresh S. Ramalingam,James Chih‐Hsin Yang,Chee Khoon Lee,Takayasu Kurata,Dong‐Wan Kim,Thomas John,Naoyuki Nogami,Yuichiro Ohe,Helen Mann,Yuri Rukazenkov,Serban Ghiorghiu,Daniel Stetson,Aleksandra Markovets,J. Carl Barrett,Kenneth S. Thress,Pasi A. Jänne |
| Citations | 544 |
| DOI | 10.1200/jco.2017.74.7576 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2747965175 |
| PMID | 28841389 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Kenneth S. Thress](https://scholariq.org/researchers/kenneth-s-thress/)
- [James Chih‐Hsin Yang](https://scholariq.org/researchers/james-chih-hsin-yang/)
- [Dong‐Wan Kim](https://scholariq.org/researchers/dong-wan-kim/)
- [Pasi A. Jänne](https://scholariq.org/researchers/pasi-a-janne/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.